4Lecca D ,Ceruti S, Fumagalli M ,et al. Purinergic trophic signalling in gIial cells:functional effects and modulation of cell proliferation, differentia- tion, and death[J]. Purinerg Signal ,2012 ;8 ( 3 ) :539-57.
5Franke H,Verkhratsky A,Bumstock G,et al. Pathophysiology of astx'ogli- alpurinergic signalling[J] Purinergic Signal ,2012 ;8 ( 3 ) :629-57.
6Popoli P, Pepponi R. Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system[J]NS Neurol Disor- tiers-Drug Targets ,2012 ; 11 (6) :664-74.
7Pagonopoulou O, ERhimiadou A, Asimakopoulos B, et of adenosine and its receptors in epilepsy:possible the[J]. Nenrosci Res ,2006 ;56 : 14-20.
8Schwartz MK, Bodansky O. Automated methods for enzyme activity [M]. Methods Biochem Analysis, 1963 ; 11 (2) :211-46.
9Faria LC, Parada I, Prince DA. Intemeuronal calcium channel abnormali- ties in posttraumatic epileptogenic neocortex[J]. Neurobiol Dis,2012;45 (2) :821-8.
10Williams-Kamesky RL, Sandau US, Lusardi TA, et al. Epigenetic chan- ges induced by adenosine augmentation therapy prevent epileptogenesis [J]. J Clin Investig,2013 ;123(8) :3552-63.
